Overview Financials News + Filings IR Vault Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Appointed CFO
Quarterly results
Appointed director
CC transcript
Inv. presentation
Director departure
|
|
INTERPACE BIOSCIENCES, INC. (IDXG)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 02/10/2022 |
SC 13G
| Singer Douglas Mark reports a 7% stake in Interpace Biosciences, Inc. |
| 09/11/2020 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 04/17/2020 |
SC 13G
| Stonepine Capital Management, LLC reports a 2.7% stake in Interpace Biosciences, Inc. |
| 06/23/2017 |
SC 13G
| ARMISTICE CAPITAL, LLC reports a 5% stake in Interpace Diagnostics Group, Inc. |
| 01/10/2017 |
SC 13G
| SABBY MANAGEMENT, LLC reports a 7.5% stake in Interpace Diagnostics Group, Inc. |
| 01/09/2017 |
SC 13G
| Empery Asset Management, LP reports a 7.5% stake in Interpace Diagnostics Group, Inc. |
| 12/19/2016 |
SC 13G
| SABBY MANAGEMENT, LLC reports a 9.9% stake in Interpace Diagnostics Group, Inc. |
| 10/19/2016 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals |
|
|